Shares of Amkor Technology vaulted 6% in pre-market to $91.76 on June 17, extending a blistering run that has carried the stock from roughly $65 in early June to fresh record territory. The catalyst: TSMC and Amkor announced a 10-year agreement to expand advanced semiconductor packaging capabilities in Arizona, strengthening investment in the U.S. semiconductor supply chain.

The deal creates a framework for TSMC to procure advanced packaging and testing services from Amkor , effectively making Amkor the back-end partner of choice for the world's dominant chipmaker on American soil.

  • A Guaranteed Customer Pipeline Changes Amkor's Risk Profile. Amkor has historically operated without long-term pricing agreements, a vulnerability its own filings flag. The partnership aims to create "a more efficient, mutually beneficial operating model" while supporting customers' evolving requirements. A decade of committed procurement from TSMC gives Amkor revenue visibility it has never had, which helps justify the $7 billion Arizona campus investment. Apple will be Amkor's first and largest customer once the campus opens, and Amkor will also supply chips to Nvidia.

  • The Numbers Demand Faith in Execution. At its May Investor Day, management targeted more than $11 billion in revenue, gross margins above 22%, and EPS exceeding $5 by 2030 — compared to $1.50 in actual 2025 EPS.

The stock's price-to-earnings ratio near 40x and price-to-sales of 2.45x already bake in meaningful growth. The TSMC agreement de-risks those targets but doesn't guarantee them.

  • Washington Is Co-Signing the Bet. Amkor's $407 million CHIPS Act award directly supports the company's roughly $2 billion initial investment in the Peoria, Arizona facility , with the total campus scope now expanded to $7 billion across two phases.

The company is also eligible for a 35% investment tax credit on qualified U.S. investments. These subsidies lower Amkor's capital burden but won't eliminate the cash-flow strain of building out what amounts to the first high-volume advanced packaging plant in the country.

  • The Stock Has Outrun Every Analyst on Wall Street. The mean analyst price target of $75.50 now sits roughly 9% below where the stock already trades.

Insiders have been net sellers, collectively disposing of $18 million more than they bought over the past 12 months. Investors are pricing in a transformed company; the question is whether the Arizona facility — on schedule for production in 2028 — can deliver before enthusiasm fades.